4
Changes in Ownership
PROTHENA CORP PUBLIC LTD CO Filed Acc 0001567619-21-004310
Options or other derivatives
- President and CEO acquired 344,700 shares (grant or award)
- President and CEO returned 517,000 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Kinney Gene G. · President and CEO
Table II: Derivative
12 lines| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2021-02-12 | Returned to the company : show line 1 in the form Employee Stock Option (Right to Buy) | −65,000 | $27.81 | 2025-03-11 | 65,000 | 0 | D |
| 2021-02-12 | Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) | +59,090 | $22.85 | 2025-03-11 | 59,090 | 59,090 | D |
| 2021-02-12 | Returned to the company : show line 3 in the form Employee Stock Option (Right to Buy) | −65,000 | $34.61 | 2026-02-24 | 65,000 | 0 | D |
| 2021-02-12 | Grant or award : show line 4 in the form Employee Stock Option (Right to Buy) | +40,625 | $22.85 | 2026-02-24 | 40,625 | 40,625 | D |
| 2021-02-12 | Returned to the company : show line 5 in the form Employee Stock Option (Right to Buy) | −50,000 | $52.21 | 2026-09-01 | 50,000 | 0 | D |
| 2021-02-12 | Grant or award : show line 6 in the form Employee Stock Option (Right to Buy) | +25,125 | $22.85 | 2026-09-01 | 25,125 | 25,125 | D |
| 2021-02-12 | Returned to the company : show line 7 in the form Employee Stock Option (Right to Buy) | −30,000 | $45.13 | 2026-11-02 | 30,000 | 0 | D |
| 2021-02-12 | Grant or award : show line 8 in the form Employee Stock Option (Right to Buy) | +16,759 | $22.85 | 2026-11-02 | 16,759 | 16,759 | D |
Loading xslF345X03/doc1.xml…